Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Svensson, J. Ankerst, L. Bjermer, E. Tufvesson (Lund, Sweden). Airway resistance and reactance in COPD patients and healthy smokers, and effect of bronchodilators. Eur Respir J 2011; 38: Suppl. 55, 4053

Member's Comments

No comment yet.

Related content which might interest you: Airway resistance variability and response to bronchodilator in children with asthma Source: Eur Respir J 2007; 30: 260-268 Year: 2007 Airway pathology in COPD compared to that in smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008 Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 Airway resistance correlates with the frequency of exacerbation in patient with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Airway resistances deteriorate following spirometry in asthma and COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Influence of smoking on airway and systemic inflammation in healthy subjects and COPD patients Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Smoking, sputum cell counts, diffusion capacity and hyperinflation predict beneficial effects of long-term inhaled corticosteroids (ICS) on FEV1-decline in patients with mild-to-moderate COPD Source: Annual Congress 2010 - COPD: management Year: 2010 Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Airway resistance in COPD Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 How the bronchodilatator in COPD patients works Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004 Restoring corticosteroid sensitivity in COPD and smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008 Effects of tiotropium on lung function in current smokers and never smokers with asthma Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 COPD and airway responsiveness to beta-agonists Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III Year: 2007 Adhesion to inhaled treatment in patients with asthma and COPD Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Dynamic compliance and reactance in older non-smokers with asthma and fixed airflow obstruction Source: Eur Respir J, 58 (2) 2004400; 10.1183/13993003.04400-2020 Year: 2021 Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005